Page last updated: 2024-11-05

cadmium oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cadmium oxide (CdO) is a bright yellow to reddish-brown crystalline solid. It is an n-type semiconductor with a wide band gap of 2.3 eV. CdO is synthesized via various methods, including direct oxidation of cadmium metal, thermal decomposition of cadmium carbonate or hydroxide, and solution-based approaches. It exhibits diverse properties, including electrical conductivity, photocatalytic activity, and optical transparency. CdO is of significant interest for various applications, including:

* **Solar cells:** CdO is used as a transparent conductive oxide (TCO) layer in solar cells to transmit sunlight while efficiently collecting electrical current.
* **Gas sensors:** CdO displays sensitivity to various gases, such as carbon monoxide, hydrogen, and ethanol, making it suitable for gas sensing applications.
* **Transistors and diodes:** CdO's semiconductor properties make it a promising material for thin-film transistors and diodes.
* **Pigments and coatings:** CdO is used as a yellow pigment in paints and coatings due to its bright color.

Cadmium oxide's widespread applications and potential for further development continue to drive research interest in its synthesis, properties, and applications.'

cadmium oxide: causes severe lung damage; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14782
MeSH IDM0094477

Synonyms (35)

Synonym
kadmu tlenek
ec 215-146-2
unii-0h3kws8kj3
cadmium oxide
cadmium oxide brown
NCGC00091341-01
1306-19-0
kadmu tlenek [polish]
caswell no. 136aa
cadmium fume
aska-rid
hsdb 1613
einecs 215-146-2
ccris 115
epa pesticide chemical code 236200
nci-c02551
cadmium oxide, powder, 99.5% trace metals basis
cadmium oxide, >=99.99% trace metals basis
oxocadmium
NCGC00260041-01
tox21_202492
tox21_111117
dtxcid104715
dtxsid0024715 ,
cas-1306-19-0
cadmium(ii) oxide
cadmium oxide fume
niosh/ev1930000
EV19300000 ,
AKOS015904020
cadmium oxide, 99.998% (metals basis)
mfcd00010921
cadmium oxide, puriss., 99.0%
Q196661
BAA30619

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Silver nanoparticles were the most toxic while molybdenum trioxide (MoO(3)) nanoparticles were the least toxic."( In vitro cytotoxicity of nanoparticles in mammalian germline stem cells.
Braydich-Stolle, L; Hofmann, MC; Hussain, S; Schlager, JJ, 2005
)
0.33
" Finally, the toxic effects of the cadmium oxide nanostructures on Madin-Darby canine kidney epithelial cells (MDCK cells), as well as the human renal cancer cell line (Caki-2 cells) were investigated using a SRB assay and two-color flow cytometry analysis."( Toxicity and efficacy of CdO nanostructures on the MDCK and Caki-2 cells.
Dillip, GR; Kim, DH; Lee, YR; Pandurangan, M; Sreekanth, TV, 2016
)
0.71
"Cadmium (Cd), classified as human carcinogen, is an extremely toxic heavy metal pollutant, and there is an increasing environmental concern for cadmium exposure through anthropogenic sources including cigarette smoke."( Effect of surfactant in mitigating cadmium oxide nanoparticle toxicity: Implications for mitigating cadmium toxicity in environment.
Anthony, SP; Balmuri, SR; Golokhvast, KS; Kumar, VV; Raman, T; Selvaraj, U; Tsatsakis, AM, 2017
)
0.73
" With increasing use of CdO NPs and concerns for their potential adverse effects on the environment and public health, evaluation of the cytotoxicity and genotoxicity of CdO NPs becomes very important."( Cytotoxicity and genotoxicity of cadmium oxide nanoparticles evaluated using in vitro assays.
Biris, AS; Chen, T; Demir, E; Ghorai, S; Guo, X; Ingle, T; Li, Y; Orza, AI; Qin, T; Yan, J; Zhang, Y; Zhou, T,
)
0.41

Bioavailability

ExcerptReferenceRelevance
"The bioavailability of heavy metals in sediments is largely controlled by their speciation."( [Bioavailability of cadmium associated with oxides in sediment: effects of species of mineral, association form and aging on bioavailability].
Jia, YF; Liu, L; Wang, H; Wang, SY, 2009
)
0.35
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" A dose-response profile of phosphorus content in the lavage fluid, which might indicate amount of surfactant produced by Type II cells was similar to that observed for beta-glucuronidase in CdO-treated rats."( Toxicity of cadmium oxide instilled into the rat lung. II. Inflammatory responses in broncho-alveolar lavage fluid.
Higo, S; Hirano, S; Suzuki, KT; Tsukamoto, N, 1989
)
0.66
"The results represented that there is a direct association between the nanoparticles applied dosage and the restrain effect augmentation of applied dosage results in increase in restrain effect."( Investigation of antibacterial effect of Cadmium Oxide nanoparticles on Staphylococcus Aureus bacteria.
Ahmadi, M; Mehrabian, S; Salehi, B, 2014
)
0.67
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency39.81070.003245.467312,589.2998AID2517
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency68.10160.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency38.61460.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency45.69900.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259403
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (152)

TimeframeStudies, This Drug (%)All Drugs %
pre-199056 (36.84)18.7374
1990's8 (5.26)18.2507
2000's18 (11.84)29.6817
2010's59 (38.82)24.3611
2020's11 (7.24)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 94.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index94.83 (24.57)
Research Supply Index5.06 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index168.45 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (94.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.64%)6.00%
Case Studies1 (0.64%)4.05%
Observational0 (0.00%)0.25%
Other155 (98.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]